Advertisement

Picture BIO Deutschland Corona Special Germany 2020 650x80px

Deals > All

Total search results: 10304 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 101 102 103 104  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Univ London–Thermo Fisher: mass spectrometer, 200907 supply UK’s first two LTQ Orbitrap Velos systems to new ICR proteomics lab 2009-07-20
BIOKÉ–Cell Signaling Technology: investment, 200907 acquisition 100% of BIOKÉ BV + renamed Cell Signaling Technology Europe BV 2009-07-09
NatuTec–eBioscience: investment, 200907 acquisition of NatuTec GmbH by eBioscience Inc 2009-07-01
Symetis–SEVERAL: investment, 200906 financing round CHF23m co-led by Wellington Partners + Vinci Capital 2009-06-29
Evotec–Cellectricon: Dynaflow system, 200906 supply purchase Dynaflow electrophysiology system for ion channel screening by Evotec 2009-06-24
Evotec–MDS: cell analysis technology, 200906 supply existent use of IonWorks Quattro + PatchXpress for ion channel screening by Evotec 2009-06-24
Evotec–Nanion: cell analysis technology, 200906 supply existent use of Patchliner + Port-a-Patch systems for ion channel screening by Evotec 2009-06-24
Evotec–Sophion: QPatch system, 200906 supply purchase Q-Patch electrophysiology platform for ion channel screening by Evotec 2009-06-24
Grifols–Fundació Clínic for Biomedical Research: human albumin, 200906– collab to develop albumin for liver cirrhosis incl funding €2m from Grifols 2009-06-11
Decision News Media–William Reed: investment, 200906 acquisition by William Reed Business Media 2009-06-04
Eufets–BioNTech: investment, 200906 acquisition by BioNTech AG 2009-06-01
Korea Basic Science Institute–Australian National Univ: mass spectrometer, 200906 supply installation SHRIMP IIe HR-SIMS from ASI 2009-06-01
IDM–Takeda: investment, 200905– acquisition $2.64/share cash tender offer announced 2009-05-18
Max Planck–Inventive Capital: financial services, 200905 service development of DDC Ventures fund by MP Innovation + Inventive Capital Advisors LLP 2009-05-14
Max Planck–Life Sciences Partners: financial services, 200905– service management of DDC Ventures fund by LSP 2009-05-14
Panatecs–CovalX: mass spectrometry, 200905– supply Panatecs to offer MALDI-TOF proteomic services using High-Mass System from CovalX 2009-05-08
Renovis–Evotec: investment, 200905 DIVESTMENT shut down of Renovis + Evotec US operations 2009-05-05
ACD/Labs–Royal Society of Chemistry: cheminformatics, 200905 collab continued integration of ChemSpider with ACD/Labs s/w products 2009-05-01
ChemZoo–Royal Society of Chemistry: investment, 200905 acquisition of ChemZoo/ChemSpider by RSC 2009-05-01
Fresenius–Trion Pharma: catumaxomab, 200712 collab existent drug registration + marketing of Removab by Fresenius Biotech 2009-04-23
Miacom Diagnostics–Inveni Capital: investment, 200904 investment by Inveni Capital 2009-04-17
Almirall–Ironwood: linaclotide, 200904– license excl marketing in Europe + CIS 2009-04-01
Sony–iCyt: flow cytometry, 200904– collab development of new flow cytometry device 2009-04-01
BioVex–SEVERAL: investment, 201003 financing round Series F 1st closing €40m 2009-03-30
Mologen–SEVERAL: investment, 200903 capital increase €2.8m 425k new shares €6.5/share to institutional investors 2009-03-27
Panatecs–Germany (govt): investment, 200903 financing round totalling €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn 2009-03-26
Panatecs–Zukunftsfonds Heilbronn: investment, 200903 financing round totalling €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn 2009-03-26
Atheso Arzneimittelsicherheit–NONE: investment, 200903–201007 bankruptcy Local Court Hanover IN 187/09 2009-03-03
Anagnostics–Niederösterreich (govt): investment, 200902 financing round totalling €3m incl VC equity from tecnet equity 2009-02-27
Heptares–SEVERAL: investment, 200902 financing round Series A £21m=$30m Clarus Ventures + MVM Life Science Partners + Novartis Option Fund 2009-02-24
PharmaKodex–Orexo: investment, 200902 acquisition 2009-02-23
MicroConstants–Waters: mass spectrometer, 200902 supply installation Micromass Q-Tof LC/MS/MS system w ACQUITY UPLC system 2009-02-04
Merck (DE)–Apitope: ATX-MS-1467, 200901– license excl ww developm + commercialisation to Merck Serono 2009-01-13
Illumina–Oxford Nanopore: BASE technology, 200901– collab + excl marketing by Illumina 2009-01-12
Oxford Nanopore–Illumina: investment, 200901 investment $18m in connection with collab + excl marketing by Illumina 2009-01-12
Oxford Nanopore–OTHER: investment, 200901 private investment £2.1m NN 2009-01-12
ChromTech–Daicel: investment, 200901 acquisition of ChromTech Ltd by Chiral Technologies Europe 2009-01-05
Bayer–Performance Plants: YPT technology, 2009– license research + commercial for use in cotton for Bayer CropScience 2009-01-01
Bayer–Tsinghua Univ: drug discovery, 2009– collab establishment of Bayer-Tsinghua Joint Research Center for Innovative Drug Discovery 2009-01-01
BIOKÉ–Cell Signaling Technology: reagents, 2009 distribution existent in Benelux by BIOKÉ 2009-01-01
BMS–Qiagen: molecular companion diagnostics, 2009– collab incl therascreen KRAS RGQ PCR Kit for Erbitux 2009-01-01
CNIO–Life Technologies: mass spectrometer, 2009 supply installation 5500qTrap hybrid MS equipped w nanoflow UPLC system at Proteomics Core Unit 2009-01-01
EndoSense–LCF Rothschild: investment, 2009 investment in EndoSense by Edmond de Rothschild Investment Partners 2009-01-01
FORTH–Thermo Fisher: mass spectrometer, 2009 supply purchase LTQ-Orbitrap XL with ETD by Proteomics Facility of IMBB-FORTH 2009-01-01
GeneBio–Swiss Institute of Bioinformatics: neXtProt knowledge platform, 20090– collab development 2009-01-01
GlycoVaxyn–LCF Rothschild: investment, 2009 investment in GlycoVaxyn by Edmond de Rothschild Investment Partners 2009-01-01
JnJ–Cenix BioScience: siRNA technology, 2009– collab improvement of siRNA-based target validation methodologies Janssen Pharmaceutica NV 2009-01-01
Kolltan–Celtic Therapeutics: investment, 2009 acquisition of minority share in Kolltan Pharmaceuticals Inc 2009-01-01
Merck (DE)–Compugen: biomarker, 2009 collab discovery of biomarker signatures for drug induced toxicity Merck Serono 2009-01-01
Merck (DE)–Compugen: biomarker, 201206 collab founding joint venture Neviah Genomics with funding from Merck + technology from Compugen 2009-01-01
Merck (US)–Sanofi-Aventis: investment, 2009 acquisition Merial remaing 50% $4b of joint venture from Merck 2009-01-01
Novartis–Nuevolution: drug discovery services, 2009– service using Chemetics technology to discover compounds against Novartis targets 2009-01-01
Novartis–Nuevolution: drug discovery technology, 201401– collab + non-excl licencse €na for using Chemetics technology with + within Novartis 2009-01-01
Peplin–Leo Pharma: investment, 2009 acquisition of Peplin Inc by Leo Pharma A/S 2009-01-01
Pistoia Alliance–Answer Consulting: bioinformatics, 2009– contributing member 2009-01-01
PZ Cussons–ACD/Labs: cheminformatics, 2009 supply replacement of prior LIMS at Seven Scent Ltd with automated quality system from ACD/Labs 2009-01-01
Sanofi–Oxford BioMedica: ophthalmic gene therapy, 2009–201902c collab developm + commerc Sanofi SEEKS NEW PARTNERS 2/19 2009-01-01
Spirogen–Celtic Therapeutics: investment, 2009 acquisition of majority share in Spirogen Ltd 2009-01-01
European Biotechnology Foundation–Biocom: investment, –200812–200912– existent Biocom AG owns 100% of EFB 2008-12-31
Domain Therapeutics–SEVERAL: investment, 200812 financing round €2.11m from new + returning investors 2008-12-15
Phytolutions–Bremen (govt): grant, 200812–201012 grant €250k for pilot project algae biofuel production from WFB Bremen within PFAU programme 2008-12-15
Domain Therapeutics–Andrew Lloyd Associates: public relations, 200812 service existent 2008-12-01
Prosensa–Gimv: investment, 200812 initial investment of Gimv in Prosensa 2008-12-01
Helsinn–Zealand Pharma: GLP-2 peptide agonist, 200811–201706 license ww excl to elsiglutide €140m milestones + royalties RIGHTS RETURNED 6/17 2008-11-01
Phenex–SEVERAL: investment, 200810 financing round €8.2m lead investor LBBW Venture 2008-10-02
Axicorp–Biocon: investment, 200810 acquisition 70% for €30m 2008-10-01
Kirin–Kyowa Hakko Kogyo: investment, 200810 merger of Kirin Pharma + Kyowa Hakko Kogyo into Kyowa Hakko Kirin 2008-10-01
SuperSonic Imagine–LCF Rothschild: investment, 200810 investment in Supersonic Imagine by Edmond de Rothschild Investment Partners 2008-10-01
Univ Applied Sciences Bremen–Bremen (govt): grant, 200810–201109 grant €68k for developm nucleases for molecular analytics WFB RnD Innovation Progr 2008-10-01
Telormedix–College Group: public relations, 200809–201109– service existent by College Hill Life Sciences 2008-09-30
Telormedix–SEVERAL: investment, 200809 financing round Series A CHF21m=€13.1m=$19m led by Aravis Venture 2008-09-30
Ciba Spezialitätenchemie–BASF: investment, 200809–200904 acquisition 2008-09-01
Merck (DE)–Ablynx: Nanobodies, 200809– collab co-discovery + co-developm Nanobodies against two targets in immunology + oncology Merck Serono 2008-09-01
Denali Therapeutics–Evotec: CNS drug discovery, 201608 strategic collab existent 2008-08-25
Denali Therapeutics–Roche: LRRK2 inhibitors, 201608 license ww excl existent to develop + commericalize LRRK2 inhibitors from Genentech 2008-08-25
Novartis–Cytos Biotechnology: Alzheimer vaccine, 200807 collab existent for CAD106 2008-07-24
Ipsogen–NewCap: public relations, 200806 service existent 2008-06-30
Mercachem–Proteros: drug discovery services, 200806– collab joint offering of services to life science industry 2008-06-23
Phytolutions–Jacobs Univ: investment, 200806 founding investors are JCBS Holding GmbH + Claudia Thomsen + Stefan Rill 2008-06-17
Phytolutions–PERSON: investment, 200806 founding investors are JCBS Holding GmbH + Claudia Thomsen + Stefan Rill 2008-06-17
Creabilis–NeoMed: investment, 200806 financing round Series A totalling €20m incl co-investor NeoMed Management 2008-06-06
Creabilis–SEVERAL: investment, 200806 financing round Series A €20m lead investor Sofinnova Partners in collab w NeoMed 2008-06-06
Creabilis–Sofinnova: investment, 200806 financing round Series A totalling €20m incl lead investor Sofinnova Partners 2008-06-06
Tercica–Ipsen: investment, 200806–200810 acquisition remaining shares $373m at $9.0/share w Tercica becoming 100% subsidiary 2008-06-05
Pieris–Novo Group: investment, 200803 financing round Series B totalling €25m incl lead investors OrbiMed Adivsors + Novo Nordisk Biotech Fund 2008-03-27
Pieris–OrbiMed: investment, 200803 financing round Series B totalling €25m incl lead investors OrbiMed Adivsors + Novo Nordisk Biotech Fund 2008-03-27
Univ Almería–Agilent: mass spectrometer, 200802 supply existent Agilent 5973 GC-MS single quad at EURL-FV 2008-02-25
Univ Almería–Agilent: mass spectrometer, 200802 supply existent Agilent 5975C GC-MS single quad at EURL-FV 2008-02-25
Univ Almería–Agilent: mass spectrometer, 200802 supply existent Agilent 6410 LC-MS/MS Triple Quad at EURL-FV 2008-02-25
Univ Almería–Agilent: mass spectrometer, 200802 supply existent Agilent 6490 LC-MS/MS Triple Quad at EURL-FV 2008-02-25
Univ Almería–Agilent: mass spectrometer, 200802 supply existent Agilent 6530 LC-MS Q-TOF at EURL-FV 2008-02-25
Univ Almería–Agilent: mass spectrometer, 200802 supply existent Agilent 7000 GC-MS/MS triple quad at EURL-FV 2008-02-25
Univ Almería–Agilent: mass spectrometer, 200802 supply existent Agilent 7200 GC-MS Q-TOF at EURL-FV 2008-02-25
Univ Almería–Applied Biosystems: mass spectrometer, 200802 supply existent Applied Biosystems LC-MS/MS QLIT at EURL-FV 2008-02-25
Univ Almería–Danaher: mass spectrometer, 200802 supply existent AB Sciex 3200 LC-MS/MS QLIT at EURL-FV 2008-02-25
Univ Almería–Danaher: mass spectrometer, 200802 supply existent AB Sciex 5500 LC-MS/MS QLIT at EURL-FV 2008-02-25
Univ Almería–Varian: mass spectrometer, 200802 supply existent Varian 3800 GC-MS/MS ion trap at EURL-FV 2008-02-25
Univ Almería–Varian: mass spectrometer, 200802 supply existent Varian 4000 GC-MS/MS ion trap at EURL-FV 2008-02-25
GSG Mess- und Analysengeräte–LECO: mass spectrometer, 200802– distribution excl of Unique LC-TOF-MS system in DE + AT + CH by GSG 2008-02-11
Applera–CovalX: mass spectrometry, 200801– collab product integration to retrofit ABI MALDI TOFs with CovalX HM1 High-Mass System 2008-01-22
next pagenext page 1 2 3 ... 101 102 103 104  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top